跳至主要内容
临床试验/ISRCTN61336225
ISRCTN61336225已完成不适用

Inhaled magnesium sulfate in the treatment of acute asthma exacerbation in children

Alexandria University0 个研究点目标入组 60 人开始时间: 2016年9月26日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Children diagnosed as asthmatic according to The Global Initiative for Asthma (GINA) guidelines
  • 2. Aged 5-14 years old
  • 3. Capable of measuring PEFR
  • 4. Presenting with moderate to severe acute exacerbation according to pediatric asthma severity score and PEFR

排除标准

  • 1. Severely ill patients requiring immediate hospital care
  • 2. Any evidence of respiratory tract infection or suppurative lung diseases
  • 3. Any history of cardiac, renal or hepatic dysfunction
  • 4. Use of short acting bronchodilator within 8 hours or long acting within 24 hours
  • 5. Use of systemic steroids within 72 hours
  • 6. Children known to have immunodeficiency
  • 7. History of previous asthmatic attacks managed by ICU admissions

研究者

相似试验